Table of Contents
Obesity is a growing health concern worldwide, and pharmacological interventions are often used as part of a comprehensive weight management program. Proper dosing of weight loss agents is critical for safety and efficacy. This article reviews the current dosing guidelines for some of the most commonly prescribed weight loss medications in clinical practice.
Orlistat
Orlistat is a lipase inhibitor that reduces fat absorption. The standard dose for adults is 120 mg three times daily with each main meal containing fat. If a meal is skipped or contains no fat, the dose can be skipped. It is important to monitor for gastrointestinal side effects and fat-soluble vitamin deficiencies.
Phentermine
Phentermine is a sympathomimetic amine used as an appetite suppressant. The typical dosing is 15 to 37.5 mg once daily in the morning to reduce insomnia. Treatment duration is generally limited to a few weeks, and dosage should be individualized based on patient response and tolerability.
Lorcaserin
Lorcaserin acts on serotonin receptors to promote satiety. The recommended dose is 10 mg twice daily. It should be used with caution in patients with a history of serotonin syndrome or other serotonergic medications.
Semaglutide
Semaglutide, a GLP-1 receptor agonist, has shown significant efficacy in weight loss. The dosing starts at 0.25 mg weekly and is gradually increased to 2.4 mg weekly as tolerated. Dose escalation should be done cautiously to minimize gastrointestinal side effects.
Contrave (Naltrexone and Bupropion)
Contrave combines naltrexone and bupropion. The usual starting dose is 8 mg naltrexone / 90 mg bupropion twice daily. Dose can be titrated up to 32 mg naltrexone / 360 mg bupropion daily, divided into two doses. Monitoring for mood changes and seizure risk is essential.
Conclusion
Effective weight management requires appropriate medication dosing tailored to individual patient needs. Clinicians should adhere to established guidelines, monitor for adverse effects, and adjust treatment as necessary. Staying informed about current dosing recommendations ensures safe and effective therapy for patients struggling with obesity.